Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry
Nishaanth Dalavaye, Simon Erridge, Martha Nicholas, et al.
Expert Review of Gastroenterology & Hepatology (2022) Vol. 17, Iss. 1, pp. 85-98
Open Access | Times Cited: 20

Showing 20 citing articles:

Cannabinoids and the Gastrointestinal Tract
Michael Camilleri, Ting Zheng
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 13, pp. 3217-3229
Closed Access | Times Cited: 13
Selected Use of Complementary and Alternative Medicine (CAM) Agents in IBD
Monica Dzwonkowski, Janak Bahirwani, Samantha Rollins, et al.
Current Gastroenterology Reports (2025) Vol. 27, Iss. 1
Closed Access
UK Medical Cannabis Registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patients
Adam Y. Li, Simon Erridge, Carl Holvey, et al.
International Clinical Psychopharmacology (2024) Vol. 39, Iss. 6, pp. 350-360
Open Access | Times Cited: 2
Supporting Machine Learning Model in the Treatment of Chronic Pain
Anna Visibelli, Luana Peruzzi, Paolo Fusar‐Poli, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1776-1776
Open Access | Times Cited: 6
A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD)
Alondra Velez-Santiago, Edwin Alvarez-Torres, Ricardo Martínez-Rodríguez, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 6, pp. 5129-5129
Open Access | Times Cited: 5
Release of delta-9-tetrahydrocannabinol from polyvinyl alcohol hydrogels and its safe interaction with human skin fibroblasts
Shujun Cui, Ze Zhang, Denis Rodrigue, et al.
Frontiers in Drug Delivery (2024) Vol. 4
Open Access | Times Cited: 1
Therapeutic Effects of Cannabinoids on Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Rajesh Kumar, Shruti Singh, Vikas Maharshi
Journal of Health Science and Medical Research (2024), pp. 20241041-20241041
Open Access | Times Cited: 1
Pharmaceutical Potential of Remedial Plants and Helminths for Treating Inflammatory Bowel Disease
Tenzin Jamtsho, Alex Loukas, Phurpa Wangchuk
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 819-819
Open Access | Times Cited: 1
Medical Cannabis Increases Appetite but Not Body Weight in Patients with Inflammatory Bowel Diseases
Naomi Fliss‐Isakov, C Seidenberg, David Meiri, et al.
Nutrients (2023) Vol. 16, Iss. 1, pp. 78-78
Open Access | Times Cited: 3
Should gastroenterologists prescribe cannabis? The highs, the lows and the unknowns
Sonia Samuel, Michael Mark, Micheal Tadros
World Journal of Clinical Cases (2023) Vol. 11, Iss. 18, pp. 4210-4230
Open Access | Times Cited: 2
An overview of global monitoring systems for the side effects and adverse events associated with medicinal cannabis use: A scoping review using a systematic approach
Rebecca Qi Wang, Yvonne Bonomo, Christine Mary Hallinan
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Overview of global monitoring systems for the side effects and adverse events associated with medicinal cannabis use: a scoping review using a systematic approach
Rebecca Qi Wang, Yvonne Bonomo, Christine Mary Hallinan
BMJ Open (2024) Vol. 14, Iss. 7, pp. e085166-e085166
Open Access
Response to the Letter to the Editor, “Refining the Understanding of Cannabis Impact on Inflammatory Bowel Disease Outcomes: Recommendations for Enhanced Research and Healthcare Practices”
Danny Glickman, Shannon Dalessio, Wesley M. Raup‐Konsavage, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. 12, pp. 2531-2532
Closed Access
The Potential of Cannabis in Managing Inflammatory Bowel Disease and Its Future Perspective
A RAUF, Mudassar Nisar, Muhammad Shaeel, et al.
Cureus (2024)
Open Access
UK medical cannabis registry: an updated analysis of clinical outcomes of cannabis-based medicinal products for inflammatory bowel disease
Aashray Gupta, Simon Erridge, Vivian Graf, et al.
Expert Review of Gastroenterology & Hepatology (2024)
Closed Access
Inflammatory bowel disease and cannabis: key counseling strategies
Jakob Saidman, Samantha Rubin, Arun Swaminath
Current Opinion in Gastroenterology (2023)
Closed Access | Times Cited: 1
Reply: “Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?”
Danny Glickman, Shannon Dalessio, Wesley M. Raup‐Konsavage, et al.
Inflammatory Bowel Diseases (2023) Vol. 29, Iss. 11, pp. e42-e43
Closed Access | Times Cited: 1
Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?
Simon Erridge, Mikael H. Sodergren
Inflammatory Bowel Diseases (2023) Vol. 30, Iss. 2, pp. 322-323
Closed Access | Times Cited: 1
Medical cannabis and neurological disorders: a clinical overview
Simon Erridge, Mikael H. Sodergren
British Journal of Neuroscience Nursing (2023) Vol. 19, Iss. Sup3, pp. S30-S34
Closed Access
Medical cannabis and attention-deficit hyperactivity disorder
Varinder Kaur, Simon Erridge, Mikael H. Sodergren, et al.
British Journal of Neuroscience Nursing (2023) Vol. 19, Iss. 2, pp. 65-70
Closed Access
Page 1

Scroll to top